You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Anoro Ellipta contains two active substances called umeclidinium and vilanterol. These belong to a group of medicines called bronchodilators.[1]

What is Anoro Ellipta used for?

Anoro Ellipta (umeclidinium/vilanterol) is used to treat chronic obstructive pulmonary disease (COPD) in adults. COPD is a long term condition characterised by breathing difficulties that slowly gets worse.[1]

In COPD the muscles around the airways tighten. This medicine blocks the tightening of these muscles in the lungs, making it easier for air to get in and out of the lungs. When used regularly, it can help to control your breathing difficulties and reduce the effects of COPD on your everyday life.[1]

For further information on Anoro Ellipta (umeclidinium and vilanterol) and potential side effects please see:

References:

  1. Anoro Ellipta 55/22mcg patient information leaflet

Anoro and Ellipta are registered trademarks of the GlaxoSmithKline group of companies.